Mitochon Pharmaceuticals is a start-up biotech company that focuses on developing drugs that target the mitochondria for a host of serious diseases.
Member count: 11-50
Total raised: $1.6M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Ben Frankl... | sep.benfra... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 25.05.2016 | - | $1.6M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 03.08.2021 | Ben Frankl... | Now like never before, i... | - | - | sep.benfra... |
| 19.05.2016 | Ben Frankl... | Recognizing the dearth o... | - | - | sep.benfra... |
| 17.05.2016 | Mitochon P... | The First Mitochondrial Target... | - | Business W... | venturebea... |
| 17.05.2016 | Mitochon P... | Mitochon Pharmaceuticals, a Bl... | USA | - | finsmes.co... |
| 12.02.2015 | Ben Frankl... | Within 20 years, BioBots... | - | - | sep.benfra... |